BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Astrocytoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Prognosis
415 results:

  • 1. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.
    Meng J; Qian W; Yang Z; Gong L; Xu D; Huang H; Jiang X; Pu Z; Yin Y; Zou J
    BMC Cancer; 2024 Mar; 24(1):317. PubMed ID: 38454344
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study.
    Miele E; Anghileri E; Calatozzolo C; Lazzarini E; Patrizi S; Ciolfi A; Pedace L; Patanè M; Abballe L; Paterra R; Maddaloni L; Barresi S; Mastronuzzi A; Petruzzi A; Tramacere I; Farinotti M; Gurrieri L; Pirola E; Scarpelli M; Lombardi G; Villani V; Simonelli M; Merli R; Salmaggi A; Tartaglia M; Silvani A; DiMeco F; Calistri D; Lamperti E; Locatelli F; Indraccolo S; Pollo B
    Cancer Lett; 2024 Apr; 588():216711. PubMed ID: 38423245
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
    Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
    [No Abstract]    [Full Text] [Related]  

  • 6. Comparative Analysis of IDH Wild-Type Multifocal and Unifocal Glioblastomas: Prognostic Factors and Survival Outcomes in Focus.
    Habiboglu R; Kayali I; Saricanbaz I; Tezcan Y
    Turk Neurosurg; 2023; 33(6):1126-1131. PubMed ID: 37846543
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
    Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
    Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Potential Prognostic Value of GATA4 Depends on the p53 Expression in Primary Glioblastoma Patients.
    Trąbska-Kluch B; Braun M; Orzechowska M; Paszek S; Zuchowska A; Sołek J; Kluska A; Fijuth J; Jesionek-Kupnicka D; Zawlik I
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372326
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Practice of IDH1, ATRX, and p53 Immunohistochemistry in Integrated Diagnosis of Adult Diffuse Gliomas: Single Center Study.
    Shabanzadeh Nejabad Z; Mabroukzadeh Kavari H; Saffar H; Tavangar SM; Sefidbakht S; Khoshnevisan A; Zare-Mirzaie A; Vasei M; Jafari E; Yaghmaii M; Saffar H
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):390-398. PubMed ID: 37278280
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.
    Quddusi DM; Bajcinca N
    IET Syst Biol; 2023 Aug; 17(4):143-161. PubMed ID: 37277696
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.
    Lee K; Kim SI; Kim EE; Shim YM; Won JK; Park CK; Choi SH; Yun H; Lee H; Park SH
    Sci Rep; 2023 Apr; 13(1):6761. PubMed ID: 37185778
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Urolithin B loaded in cerium oxide nanoparticles enhances the anti-glioblastoma effects of free urolithin B in vitro.
    Rahimi-Kalateh Shah Mohammad G; Motavalizadehkakhky A; Darroudi M; Zhiani R; Mehrzad J; Afshari AR
    J Trace Elem Med Biol; 2023 Jul; 78():127186. PubMed ID: 37148696
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mutational landscape of primary spinal cord astrocytoma.
    Cheng L; Zhang F; Zhao X; Wang L; Duan W; Guan J; Wang K; Liu Z; Wang X; Wang Z; Wu H; Chen Z; Teng L; Li Y; Xiao F; Fan T; Jian F
    J Pathol; 2023 Jul; 260(3):317-328. PubMed ID: 37114614
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of INSRR as an immune-related gene in the tumor microenvironment of glioblastoma by integrated bioinformatics analysis.
    Zhang H; Bao M; Liao D; Zhang Z; Tian Z; Yang E; Luo P; Jiang X
    Med Oncol; 2023 Apr; 40(6):161. PubMed ID: 37099121
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma.
    Ebrahimi S; Mirzavi F; Hashemy SI; Khaleghi Ghadiri M; Stummer W; Gorji A
    Biofactors; 2023; 49(4):900-911. PubMed ID: 37092793
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis.
    Lu W; Li D; Tao F; Chen Q; Fan S; Ma Y; Dong H; Hu Y; Yue C
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1340-1353. PubMed ID: 37056065
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Flubendazole exhibits anti-glioblastoma effect by inhibiting STAT3 and promoting cell cycle arrest.
    Vítovcová B; Skarková V; Havelek R; Soukup J; Pande A; Caltová K; Rudolf E
    Sci Rep; 2023 Apr; 13(1):5993. PubMed ID: 37045903
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Hsa_circITGA4/ miR-1468/EGFR/ PTEN a Master Regulators Axis in Glioblastoma Development and Progression.
    Tutunchi S; Bereimipour A; Ghaderian SMH
    Mol Biotechnol; 2024 Jan; 66(1):90-101. PubMed ID: 37031335
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents.
    Salerno S; Barresi E; Baglini E; Poggetti V; Da Settimo F; Taliani S
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985576
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].
    Yang QY; Li MN; Chen TY; Liu C; Li X; Shi ZM; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):376-383. PubMed ID: 36973199
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 21.